Life Sciences

Revealed: UK patients stockpile drugs in fear of no-deal Brexit

January 21, 2019

Ministers have been urged by top doctors to reveal the extent of national drug stocks, amid growing evidence patients are stockpiling medication in preparation for a no-deal Brexit. The Royal College of Physicians (RCP), which represents tens of thousands of doctors, urged the government to..

No bidding war for Loxo, so did Lilly overpay? Don’t rush to judgment, analysts say

January 21, 2019

When Eli Lilly announced during the recent J.P. Morgan Healthcare Conference that it would buy Loxo Oncology for $8 billion—a 68% premium—some analysts assumed there must have been a bidding war for the developer of targeted cancer drugs. But SEC documents reveal that’s not the..

Digital Therapeutics will transform Pharma and healthcare industries in 2019. Here’s how.

The future will see the pharma industry change two things: what and how it sells. As payers become more focused on Value Based Contracts (VBCs), the days of pay-per-pill are disappearing. Drugs will remain core but they will be augmented by a portfolio of digital..

Novartis CEO who wanted to bring tech into pharma now explains why it’s so hard

The current challenge for data science and technology (DST) in healthcare is moving beyond the “dancing bear” stage, where “the wonder is not how well the bear dances, but that he dances at all.” It’s time for DST to evolve past the novelty publications and..

Reckitt CEO plots exit amid consumer health split, and investors aren’t happy

January 17, 2019

Back in 2017, Reckitt Benckiser CEO Rakesh Kapoor touched off some big changes for the company. But he won’t be sticking around long enough to see them through. Wednesday, the consumer giant said Kapoor, bound for retirement, would be leaving his post by the end..

Bayer to shutter Pennsylvania site, cut loose 600-plus workers

January 17, 2019

As part of a global overhaul that will cut 12,000 jobs, Bayer is consolidating its corporate functions—and it’s starting by shutting down operations in Robinson, Pennsylvania, near Pittsburgh. The shutdown means 569 employees and 96 contractors will be cut over the next two years, Bayer..

Pharma comments on Brexit withdrawal rejection

January 16, 2019

Pharmaceutical groups have weighed in on the UK parliament’s rejection of the Brexit withdrawal agreement. Commenting on the decision made by UK parliament to vote down Prime Minister Theresa May’s Brexit withdrawal agreement, the European Federation of Pharmaceutical Industries and Associations (EFPIA) urged negotiators to..

Roche R&D executive begins a new voyage with biotech move

January 16, 2019

Another day, another Big Pharma executive jumping ship to biotech. On Tuesday morning, it was Omar Khwaja, M.D., Ph.D., who became chief medical officer at gene therapy specialist Voyager Therapeutics. Khwaja was a top research executive at Roche, leaving his dual positions as global head..

Want to win over payers, pharma? Forget the ‘me-too’ drugs, CSL chief says

January 15, 2019

If payers are looking askance at certain new drugs, there’s good reason, CSL Chief Executive Paul Perreault figures. Pharma is too preoccupied with short-term growth, so it’s still going for the easier “me-too” route rather than focusing on “transformative” therapies. In his 35-plus years of..

Here’s why we need way more women in healthcare leadership

Women are the primary healthcare decision makers, often labeled the “chief medical officer” of their homes and beyond. In fact, they make 80% of all buying and usage decisions. Not to mention, they also constitute over 70% of the healthcare workforce. And yet women are..